Mr. Lionel P. Segard is the Chairman of the Board and Chief Executive Officer of Quantum Genomics Corporation. Q.G.C. is a global biotechnology corporation based in Jersey City, New Jersey with their European headquarters in France. The company maximizes developments and discoveries of academic research into breakthrough treatments for human disease. QGC creates research and development teams that include the company’s own internal resources as well as accessing well known physicians and researchers from the best academic and scientific institutions to expedite the process from discovery phase to market introduction. Cardiovascular disease, neurology, and metabolic related diseases are focus areas for QGC’s research projects.

As C.E.O of Quantum Genomics Corporation, Mr. Segard oversees the company’s strategies and financial planning. He has been QGC’s leader since June of 2006. Lionel Segard is a proficient biochemist and is a leading expert in sourcing, developing, and financing innovative biotechnology projects. He has extensive experience in building teams of experts from a variety of backgrounds. Before heading QGC he was C.E.O. of the French National Institute of Health (INSERM). He is a founding member of France’s Strategic Council for Innovation, where he was secretary general from 2003-2005. He began his career as a scientist at IBM. From 1999-2002 he served as C.E.O. of 24/7 Media’s French subsidiary. Around this time he was co-founder of Eurobiobiz, a company that worked with the E.U. to create and develop European Biotechnology companies and advise investment funds.

Lionel Segard graduated in Biochemistry from Université Paris-Sud 11. He prefers physical forms of recreation. He finds skiing exhilarating. Mr. Segard is a practitioner of Aikido, which melds together his inner and corporeal strengths.

Mr. Lionel P. Segard can be found in the Madison Who’s Who Directory and he is looking forward to networking with you.

www.quantum-genomics.com